Department of Gastrointestinal Surgery, San Raffaele Hospital IRCCS, 20132 Milan, Italy.
Research Institute against Digestive Cancer (IRCAD), 67000 Strasbourg, France.
Cells. 2023 Feb 13;12(4):603. doi: 10.3390/cells12040603.
The remarkable capacity of regeneration of the liver is well known, although the involved mechanisms are far from being understood. Furthermore, limits concerning the residual functional mass of the liver remain critical in both fields of hepatic resection and transplantation. The aim of the present study was to review the surgical experiments regarding liver regeneration in pigs to promote experimental methodological standardization. The Pubmed, Medline, Scopus, and Cochrane Library databases were searched. Studies evaluating liver regeneration through surgical experiments performed on pigs were included. A total of 139 titles were screened, and 41 articles were included in the study, with 689 pigs in total. A total of 29 studies (71% of all) had a survival design, with an average study duration of 13 days. Overall, 36 studies (88%) considered partial hepatectomy, of which four were an associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Remnant liver volume ranged from 10% to 60%. Only 2 studies considered a hepatotoxic pre-treatment, while 25 studies evaluated additional liver procedures, such as stem cell application, ischemia/reperfusion injury, portal vein modulation, liver scaffold application, bio-artificial, and pharmacological liver treatment. Only nine authors analysed how cytokines and growth factors changed in response to liver resection. The most used imaging system to evaluate liver volume was CT-scan volumetry, even if performed only by nine authors. The pig represents one of the best animal models for the study of liver regeneration. However, it remains a mostly unexplored field due to the lack of experiments reproducing the chronic pathological aspects of the liver and the heterogeneity of existing studies.
肝脏具有很强的再生能力,这一点众所周知,但其具体机制仍远未被完全阐明。此外,无论是在肝切除术还是肝移植领域,肝脏的剩余功能质量仍然是一个关键限制因素。本研究旨在回顾猪的肝脏再生外科实验,以促进实验方法学的标准化。我们检索了 Pubmed、Medline、Scopus 和 Cochrane Library 数据库。纳入评估猪肝脏再生的外科实验研究。共筛选出 139 个标题,最终纳入 41 篇文章,共涉及 689 头猪。其中 29 项研究(占所有研究的 71%)采用生存设计,平均研究时间为 13 天。总体而言,36 项研究(88%)考虑了部分肝切除术,其中 4 项研究采用联合肝脏分割和门静脉结扎分期肝切除术(ALPPS)。剩余肝体积范围为 10%至 60%。仅有 2 项研究考虑了肝毒性预处理,而 25 项研究评估了其他肝脏操作,如干细胞应用、缺血/再灌注损伤、门静脉调制、肝支架应用、生物人工肝和药物性肝治疗。仅有 9 位作者分析了细胞因子和生长因子如何响应肝切除术而发生变化。评估肝脏体积最常用的影像学系统是 CT 扫描体层摄影术,但仅有 9 位作者使用。猪是研究肝脏再生的最佳动物模型之一。然而,由于缺乏能够复制肝脏慢性病理特征的实验以及现有研究的异质性,该领域仍在很大程度上未被探索。